Rhino‐Orbital‐Cerebral Mucormycosis With Bilateral Endogenous Aspergillus Endophthalmitis Following Steroid Therapy for COVID‐19 Infection
Case Reports in Ophthalmological Medicine · 2026-01 · 2026 (1)
DOI: 10.1155/crop/6610355 ↗Kurz gefasst
Fachartikel in der Zeitschrift Case Reports in Ophthalmological Medicine, online erschienen am 07.06.2026. Verfasst von Nasser Shoeibi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Eye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran, mums.ac.ir. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
We report a diabetic patient with rhino‐orbital‐cerebral mucormycosis (ROCM) and bilateral endogenous Aspergillus endophthalmitis post‐coronavirus disease 2019 (COVID‐19) infection. Case Report A 45‐year‐old man who had diabetes experienced vision loss and sought medical assistance. Prior to developing orbital symptoms, he had undergone intensive corticosteroid therapy for COVID‐19. His uncorrected visual acuity was 20/20 in the right eye, but he had no light perception in his left eye. While hospitalized for ROCM, he developed endogenous endophthalmitis in his left eye, which was caused by Aspergillus fumigatus. Additionally, Aspergillus retinitis was diagnosed in his right eye due to the development of white retinal lesions and preretinal hemorrhage. To treat ROCM, he received systemic and retrobulbar injections of amphotericin B, which led to regression. Posaconazole was prescribed for the treatment of Aspergillus endophthalmitis. The retinitis lesions in his right eye responded well to oral posaconazole without any long‐term complications.
Conclusion
Patients with COVID‐19‐associated immunodeficiency may be more vulnerable to opportunistic pathogens, such as mucormycosis and Aspergillus, particularly if they have comorbidities like diabetes mellitus. It is also possible for one person to be coinfected with multiple opportunistic pathogens.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Eye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran, mums.ac.ir.
ORCID-Profile: Nasser Shoeibi, Mohammad Etezad Razavi, Farid Shekarchian, Hamid Reza Heidarzadeh, Seyedeh Maryam Hosseini
Zitieren
APA
Shoeibi, N., Etezad Razavi, M., Shekarchian, F., Heidarzadeh, H. R., & Hosseini, S. M. (2026). Rhino‐Orbital‐Cerebral Mucormycosis With Bilateral Endogenous Aspergillus Endophthalmitis Following Steroid Therapy for COVID‐19 Infection. Case Reports in Ophthalmological Medicine, 2026(1). https://doi.org/10.1155/crop/6610355
Vancouver
Shoeibi N, Etezad Razavi M, Shekarchian F, Heidarzadeh HR, Hosseini SM. Rhino‐Orbital‐Cerebral Mucormycosis With Bilateral Endogenous Aspergillus Endophthalmitis Following Steroid Therapy for COVID‐19 Infection. Case Reports in Ophthalmological Medicine. 2026;2026(1). doi:10.1155/crop/6610355
BibTeX
@article{Shoeibi2026,
author = {Shoeibi, Nasser and Etezad Razavi, Mohammad and Shekarchian, Farid and Heidarzadeh, Hamid Reza and Hosseini, Seyedeh Maryam},
title = {Rhino‐Orbital‐Cerebral Mucormycosis With Bilateral Endogenous Aspergillus Endophthalmitis Following Steroid Therapy for COVID‐19 Infection},
journal = {Case Reports in Ophthalmological Medicine},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crop/6610355}
}
EUVIMED